Administration of a P2X7 receptor binding nanobody intracerebroventricularly has been shown to reduce stroke lesions in a mouse model but P2X7 receptor binding nanobodies were not effective after intravenous administration [56], further emphasizing the importance of BBB penetration. The gene discussed is P2RX7; the disease is stroke disorder.